Your browser doesn't support javascript.
loading
Xpert MTB/RIF Ultra on contaminated liquid cultures for tuberculosis and rifampicin-resistance detection: a diagnostic accuracy evaluation.
Ghebrekristos, Yonas T; Beylis, Natalie; Centner, Chad M; Venter, Rouxjeane; Derendinger, Brigitta; Tshivhula, Happy; Naidoo, Selisha; Alberts, Rencia; Prins, Bronwyn; Tokota, Anitta; Dolby, Tania; Marx, Florian; Omar, Shaheed V; Warren, Robin; Theron, Grant.
Afiliação
  • Ghebrekristos YT; DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa; National Health Lab
  • Beylis N; National Health Laboratory Service, Greenpoint Tuberculosis Laboratory, Cape Town, South Africa; Division of Medical Microbiology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Centner CM; National Health Laboratory Service, Medical Microbiology, Groote Schuur Hospital, Cape Town, South Africa; Division of Medical Microbiology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Venter R; DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
  • Derendinger B; DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
  • Tshivhula H; DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
  • Naidoo S; Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
  • Alberts R; DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
  • Prins B; National Health Laboratory Service, Greenpoint Tuberculosis Laboratory, Cape Town, South Africa.
  • Tokota A; National Health Laboratory Service, Greenpoint Tuberculosis Laboratory, Cape Town, South Africa.
  • Dolby T; National Health Laboratory Service, Greenpoint Tuberculosis Laboratory, Cape Town, South Africa.
  • Marx F; Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Health Sciences, Stellenbosch University, Cape Town, South Africa; DSI-NRF South African Centre of Excellence in Epidemiological Modelling and Analysis, Stellenbosch University, Cape Town, South Africa; Division of Infect
  • Omar SV; Centre for Tuberculosis, National TB Reference Laboratory, National Institute for Communicable Diseases a division of the National Health Laboratory Service, Johannesburg, South Africa; Department of Medical Microbiology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
  • Warren R; DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
  • Theron G; DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa. Electronic address:
Lancet Microbe ; 4(10): e822-e829, 2023 10.
Article em En | MEDLINE | ID: mdl-37739001
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose / Antibióticos Antituberculose / Mycobacterium tuberculosis Tipo de estudo: Diagnostic_studies Limite: Humans País como assunto: Africa / America do norte Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose / Antibióticos Antituberculose / Mycobacterium tuberculosis Tipo de estudo: Diagnostic_studies Limite: Humans País como assunto: Africa / America do norte Idioma: En Ano de publicação: 2023 Tipo de documento: Article